More Articles

Maximizing Use of Multidose Vials

There are 10 doses in each multidose vial. To help ensure that you’re able to retrieve all 10 doses, we’ve outlined a few tips below.

Read More

Strain Recommendations for the 2018-2019 Flu Season

The World Health Organization (WHO) has recommended that quadrivalent vaccines for the 2018-2019 northern hemisphere influenza season contain the following:

Read More

Fluad Projected To Begin Shipping Week of August 6, 2018

According to communications with Seqirus, NMS projects Fluad shipments will begin the week of August 6th.

Read More

NMS TO BEGIN SHIPPING FLU VACCINE AUGUST 2018

According to communications from both Sanofi and Seqirus flu vaccine presentations from both manufacturers will begin shipping in August 2018. If your facility or practice prefers to have flu vaccine in stock early to offer to your patients please reach out to schedule an early delivery of vaccine.

Read More

Effectiveness of Flu Vaccine

The CDC reports that the 2017/18 flu vaccine had an efficacy percentage of 36%.

Read More

What To Do If You Get the Flu

This year's flu season has been particularly difficult with a significantly larger population suffering from exposure. Influenza activity historically has begun in October and lasts until February. With the flu season in full swing, here are some tips on what to do if you contract the flu virus:

Read More

NMS Still Shipping Vaccine

NMS continues to ship flu vaccine from the 2017/18 season.

Read More

Trivalent Vaccine Still Available

NMS is still shipping Trivalent flu vaccine. While many other suppliers are stocked out NMS continues to offer this option to healthcare providers.

Read More

Afluria Quadrivalent Vaccine - Age Indication Update

The FDA has extended the age indication for the Afluria Quadrivalent vaccine from 18 years of age or older to approval for use in individuals 5 years and older.

Read More

Flu Vaccine FAQ

Influenza Vaccine FAQ

Read More

Sanofi Pasteur and GSK Begin to Ship Flu Vaccine for 2017/18 Season

The U.S. Food and Drug Administration (FDA) has released the first doses of influenza vaccine manufactured by Sanofi Pasteur and GSK. Sanofi is projected to manufacture 70 million doses for this year's flu season. GSK expects to supply up to 40 million doses.

Read More

Microneedle Pain-Free Patch Could Soon Replace Flu Shot

A bandage-like microneedle patch could soon replace the traditional flu shot.

Read More

CDC Characterizes 2016/17 Flu Season as "Moderate"

According to CDC researchers the 2016/17 season had "moderate" influenza activity with influenza A (H3N2) the most frequently reported strain. Influenza activity peaked in the middle of February 2017. Influenza B appeared to be the more common strain from March through May.

Read More

Sanofi Purchases US Flu Vaccine Manufacturer Protein Sciences

Sanofi, a French multinational pharmaceutical company, has agreed to purchase US based Protein Sciences. In addition to Sanofi's current flu vaccine line up, the acquisition will expand their flu portfolio with non-egg based flu vaccine.

Read More

Trivalent Vaccine Still Available to Pre-Book

NMS is still accepting pre-book orders for Fluvirin and/or Afluria trivalent multi-dose vials. These two presentations are sold out with most other suppliers. Place your orders now!

Read More
Read More Articles